Trial Identifier: | D7960C00008 |
Sponsor: | AstraZeneca |
Start Date: | December 2024 |
Primary Completion Date: | June 2027 |
Study Completion Date: | June 2027 |
Condition: | Heart, Blood & Circulatory - Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
CN | Baotou, CN, 14010 |
CN | Beijing, CN, 100029 |
CN | Beijing, CN, 100050 |
CN | Bengbu, CN, 233004 |
CN | changchun, CN, 130021 |
CN | Changchun, CN, 130033 |
CN | Changde, CN, 415003 |
CN | changsha, CN, 410015 |
CN | Changzhou, CN, 272100 |
CN | Chengdu, CN, 610000 |
CN | Chongqing, CN, 402260 |
CN | Deyang, CN, 618000 |
CN | Guangzhou, CN, 510220 |
CN | Guangzhou, CN, 510100 |
CN | Hengyang, CN, 421001 |
CN | Heze, CN, 274099 |
CN | Linhai, CN, 317000 |
CN | Luoyang, CN, 471000 |
CN | Nanchang, CN, 330009 |
CN | Nanchong, CN, 637900 |
CN | Nanjing, CN, 210009 |
CN | Pingxiang, CN, 337055 |
CN | sanya, CN, 572000 |
CN | Shanghai, CN, 200032 |
CN | Shanghai, CN, 310000 |
CN | Shanghai, CN, 200120 |
CN | Siping, CN, 136000 |
CN | Taiyuan, CN, 030024 |
CN | Tianjin, CN, 300457 |
CN | Wuhan, CN, 430030 |
CN | Wuhan, CN, 430010 |
CN | Wuhan, CN, 430060 |
CN | Xi'an, CN, 710068 |
CN | Xianyang, CN, 750004 |
CN | Yinchuan, CN, 750004 |
CN | Zigong, CN, 643021 |
HK | Hong Kong, HK |
HK | Hong Kong, HK, 999077 |
HK | Shatin, HK, 00000 |